Pioglitazone Hydrochloride Tablet
Product Images NDC 71335-9664

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pioglitazone Hydrochloride (NDC 71335-9664). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713359664)

Label (Lbl713359664)
This is a drug label for Pioglitazone Hydrochloride Tablets that come in 30mg dosage. The label includes details on drug composition, storage, and safety, including keeping the drug out of reach of children. The product is made by Aurobindo Pharma, and the tablets are repackaged by Bryant Ranch Prepack, Inc. The label includes USP controlled room temperature guidelines for storage.*
FDA Label Image

Figure 1 Shows The Time Course For Changes In Hba1c In This 26-week Study (Pioglitazone Fig1)

Figure 1 Shows The Time Course For Changes In Hba1c In This 26-week Study (Pioglitazone Fig1)
The text describes the results of a dose-ranging study that lasted for 26 weeks, focusing on changes observed in HbAlc levels in relation to a placebo medication. The figure shows a graph with the mean change from baseline values for the observed HbAlc levels measured over the study duration, in which three different doses were tested (15mg, 30mg, 45mg). The graph also shows a time course from 0 to 26 weeks, indicating a peak of change around week 12.*
FDA Label Image

Chemical Structure (Pioglitazone Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.